BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3134297)

  • 1. IL-1 and IFN-gamma increase vascular permeability.
    Martin S; Maruta K; Burkart V; Gillis S; Kolb H
    Immunology; 1988 Jun; 64(2):301-5. PubMed ID: 3134297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular hyperpermeability induced by tumor necrosis factor and its augmentation by IL-1 and IFN-gamma is inhibited by selective depletion of neutrophils with a monoclonal antibody.
    Abe Y; Sekiya S; Yamasita T; Sendo F
    J Immunol; 1990 Nov; 145(9):2902-7. PubMed ID: 2120340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats.
    Gardiner SM; Kemp PA; March JE; Woolley J; Bennett T
    Br J Pharmacol; 1998 Dec; 125(7):1543-50. PubMed ID: 9884083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells.
    Pang L; Knox AJ
    Br J Pharmacol; 1997 Jun; 121(3):579-87. PubMed ID: 9179403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in interleukin 2-induced vascular leakage in the lungs of mice by administration of recombinant interleukin 1 alpha in vivo.
    Puri RK; Travis WD; Rosenberg SA
    Cancer Res; 1989 Feb; 49(4):969-76. PubMed ID: 2783561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha.
    Murakami A; Kawabata K; Koshiba T; Gao G; Nakamura Y; Koshimizu K; Ohigashi H
    Cancer Res; 2000 Nov; 60(22):6326-31. PubMed ID: 11103793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cytokine production in interferon-gamma-primed mice, challenged with lipopolysaccharide. Inhibition by SK&F 86002 and interleukin-1 beta-converting enzyme inhibitor.
    Spinelle-Jaegle S; Devillier P; Doucet S; Millet S; Banissi C; Diu-Hercend A; Ruuth E
    Eur Cytokine Netw; 2001; 12(2):280-9. PubMed ID: 11399517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13.
    Marfaing-Koka A; Devergne O; Gorgone G; Portier A; Schall TJ; Galanaud P; Emilie D
    J Immunol; 1995 Feb; 154(4):1870-8. PubMed ID: 7530744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1alpha regulates Thy-1 expression on rat vascular endothelial cells.
    Ishizu A; Ishikura H; Nakamaru Y; Kikuchi K; Koike T; Yoshiki T
    Microvasc Res; 1997 Jan; 53(1):73-8. PubMed ID: 9056477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of a macrophage-like nitric oxide synthase in cultured rat aortic endothelial cells. IL-1 beta-mediated induction regulated by tumor necrosis factor-alpha and IFN-gamma.
    Suschek C; Rothe H; Fehsel K; Enczmann J; Kolb-Bachofen V
    J Immunol; 1993 Sep; 151(6):3283-91. PubMed ID: 7690801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma.
    Issekutz AC; Issekutz TB
    J Immunol; 1993 Aug; 151(4):2105-15. PubMed ID: 8345197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human interleukin 2 analogues that preferentially bind the intermediate-affinity interleukin 2 receptor lead to reduced secondary cytokine secretion: implications for the use of these interleukin 2 analogues in cancer immunotherapy.
    Heaton KM; Ju G; Grimm EA
    Cancer Res; 1993 Jun; 53(11):2597-602. PubMed ID: 8495422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 1 alpha and gamma-interferon induction of nitric oxide production from murine tumor-derived endothelial cells.
    Chang MJ; Modzelewski RA; Russell DM; Johnson CS
    Cancer Res; 1996 Feb; 56(4):886-91. PubMed ID: 8631029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine.
    Bamforth SD; Lightman SL; Greenwood J
    Am J Pathol; 1997 Jan; 150(1):329-40. PubMed ID: 9006348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inflammatory cytokines on the metabolism of low-density lipoproteins by human vascular endothelial cells.
    Klein RL; Ascenção JL; Mironova M; Huang Y; Lopes-Virella MF
    Metabolism; 2001 Jan; 50(1):99-106. PubMed ID: 11172482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of human endothelial cell activation by antiproliferative cytokines: exploration of arachidonic acid and intracellular cytokine pathways as possible mechanisms of action.
    Delomenie C; Wautier-Pepin MP; Chappey O; Wautier JL
    Exp Cell Res; 1993 Jul; 207(1):122-30. PubMed ID: 7686496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 and tumor necrosis factor-mediated regulation of C3 gene expression in human astroglioma cells.
    Barnum SR; Jones JL; Benveniste EN
    Glia; 1993 Mar; 7(3):225-36. PubMed ID: 8454308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
    Nicoletti F; Di Marco R; Patti F; Zaccone P; L'Episcopo MR; Reggio E; Xiang M; Nicoletti A; Reggio A
    Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.